COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 862: Articles 8611-8620  | Next

In vitro Characterization of SARS-CoV-2 Protein Translated from the Moderna mRNA-1273 Vaccine
Veenstra, T., Injeti, E., Pauley, B.
10.1101/2022.03.01.22271618 — Posted: 2022-03-02
Racial/Ethnic Disparities in the Observed COVID-19 Case Fatality Rate Among the U.S. Population
Schumm, L. P., Giurcanu, M. C., Locey, K. J., Ortega, J. C., Zhang, Z., Grossman, R. L.
10.1101/2022.03.01.22271708 — Posted: 2022-03-02
Longitudinal monitoring of SARS-CoV-2 neutralizing antibody titers and its impact on employee personal wellness decisions
Vandergaast, R., Carey, T., Suksanpaisan, L., Lathrum, C., Narjari, R., Haselton, M., Schnebeck, L., Wijesekara, A., Duncan, A., Russell, L., Naik, S., Peng, K.-W., Lech, P., Russell, S. J.
10.1101/2022.03.01.22271202 — Posted: 2022-03-02
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern
Li, M., Beck, E. J., Laeyendecker, O., Eby, Y. J., Tobian, A. A., Caturegli, P., Wouters, C., Chiklis, G., Block, W., McKie, R., Joyner, M., Wiltshire, T. D., Dietz, A. B., Gniadek, T. J., Shapiro, A., Yarava, A., Lane, K., Hanley, D. F., Bloch, E. M. M., Shoham, S., Cachay, E., Meisenberg, B. R., Huaman, M., Fukuta, Y., Patel, B., Heath, S. L., Levine, A. C., Paxton, J. H., Shweta, A., Gerber, J., Gebo, K. A., Casadevall, A., Pekosz, A., Sullivan, D. J., COVID-19 Serologic Studies Consortium (CSSC)
10.1101/2022.03.01.22271662 — Posted: 2022-03-02
Viral cultures, Polymerase Chain Reaction Cycle Threshold Values and Viral Load Estimation for SARS-CoV-2 Infectious Potential Assessment in Hematopoietic Stem Cell and Solid Organ Transplant Patients: A Systematic Review
Jefferson, T., Spencer, E. A., Rosca, E. C., Maltoni, S., Brassey, J., ONAKPOYA, I., Pluddemann, A., Evans, D. H., Conly, J. M., Heneghan, C.
10.1101/2022.03.01.22271684 — Posted: 2022-03-02
COVID-19 in Tunisia (North Africa): IgG and IgG subclass antibody responses to SARS-CoV-2 according to disease severity
Benabdessalem, C., Marzouki, S., Ben Hamouda, W., Trabelsi, K., Boumaiza, M., Ben Hamouda, S., Ouni, R., Bchiri, S., Chaaban, A., Gdoura, M., Gorgi, Y., Sfar, I., Yalaoui, S., Ben Khelil, J., Hamzaoui, A., Abdallah, M., Cherif, Y., Petres, S., Mok, C. K. P., Escriou, N., Quesney, S., Dellagi, K., Bettaieb, J., Rourou, S., Barbouche, M. R., Ben Ahmed, M.
10.1101/2022.03.01.22271696 — Posted: 2022-03-02
Transcriptomic clustering of critically ill COVID-19 patients
Lopez-Martinez, C., Martin-Vicente, P., Gomez de Ona, J., Lopez-Alonso, I., Gil-Pena, H., Cuesta-Llavona, E., Fernandez-Rodriguez, M., Crespo, I., Salgado del Riego, E., Rodriguez-Garcia, R., Parra, D., Fernandez, J., Rodriguez-Carrio, J., Davalos, A., Chapado, L. A., Coto, E., Albaiceta, G. M., Amado-Rodriguez, L.
10.1101/2022.03.01.22271576 — Posted: 2022-03-02
Ammonium Sulfate Addition Reduces the Need for Guanidinium Isothiocyanate in the Denaturing Transport Medium Used for SARS-COV-2 RNA Detection
Liu, G., Jia, J., Zhong, J., Jiang, H., Yang, Y., Lu, X., He, Z., Zhu, Q.
10.1101/2022.02.28.22271591 — Posted: 2022-03-02
Patients with CLL have similar high risk of death upon the omicron variant of COVID-19 as previously during the pandemic.
Niemann, C. U., da Cunha-Bang, C., Helleberg, M., Ostrowski, S. R., Brieghel, C.
10.1101/2022.03.01.22271685 — Posted: 2022-03-02
Assessment of Potential Risk Factors for COVID-19 among Health Care Workers in a Health Care Setting in Delhi, India -A Cohort Study
Dudeja, M., Shaikh, A., Islam, F., Alvi, Y., Ahmad, M., Kashyap, V., Singh, V., Rahman, A., Panda, M., Shree, N., Nandy, S., Jain, V.
10.1101/2022.02.28.22271674 — Posted: 2022-03-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).